Psychemedics Corporation Announces Sales & Marketing Agreement with Bupa in UK
News Release PSYCHEMEDICS CORPORATION ANNOUNCES SALES & MARKETING AGREEMENT WITH BUPA IN UK Acton, Massachusetts, May 19, 2009 – Psychemedics Corporation (NASDAQ: PMD) today announced that it has signed a sales and marketing agreement with leading international health and care organization Bupa, to market the patented Psychemedics hair analysis drug test in the UK. Around … Read more